Neuphoria Therapeutics Inc. (NEUP)

Neuphoria Therapeutics Revenue

Neuphoria Therapeutics had revenue of $15.65M in the twelve months ending September 30, 2025. In the fiscal year ending June 30, 2025, Neuphoria Therapeutics had annual revenue of $15.65M.

• Revenue (ttm): $15.65M
• Revenue Growth: n/a
• P/S Ratio: 0.56
• Revenue / Employee: $1,956,181
• Employees: 8
• Market Cap: 11.18M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	15.65M	-	-
Jun 30, 2024	-	-	-
Jun 30, 2023	-	-	-
Jun 30, 2022	4.17M	3.48M	499.60%
Jun 30, 2021	695.81K	-1.37M	-66.32%